Table 11. Comparison of TMZ effects on hearts subjected to AHF—Lean males vs. lean females (luteal) (n = 6).
| Control | ||||||
| Parameters | Males | Females | Sig. | |||
| Heart rate (%) |
210.13 ± 127.11 | 33.55 ± 4.86 | ns | |||
| LVDevP (%) |
1259.06 ± 485.90 | 6116.62 ± 1675.88 | * | |||
| LVEDP (%) |
201.85 ± 36.57 | 179.64 ± 10.82 | ns | |||
| LVESP (%) |
211.06 ± 43.49 | 199.59 ± 13.44 | ns | |||
| TMZ at CAHF | TMZ at RAHF | |||||
| Males | Females | Sig. | Males | Females | Sig. | |
| Heart rate (%) |
28.26 ± 1.48 | 34.18 ± 5.60 | ns | 29.74 ± 2.23 | 27.31 ± 1.41 | ns |
| LVDevP (%) |
2204.29 ± 355.33 | 6202.00 ± 1064.64 | ns | 6025.70 ± 654.65 | 9475.80 ± 1807.90 | ns |
| LVEDP (%) |
160.23 ± 9.38 | 176.24 ± 43.51 | ns | 158.26 ± 18.72 | 134.06 ± 4.27 | ns |
| LVESP (%) |
170.36 ± 11.07 | 194.08 ± 51.29 | ns | 171.80 ± 24.07 | 147.00 ± 6.88 | ns |
Data represent the last ten minutes of the RAHF phase and expressed as a percentage of CAHF. Significance is expressed as *p<0.05. LVDevP: left ventricular developed pressure; LVEDP: left ventricular end diastolic pressure; LVESP: left ventricular end systolic pressure; CAHF: critical acute heart failure; RAHF: recovery acute heart failure; Sig.: significance; ns: not significant.